Publications

Department of Medicine faculty members published more than 3,600 peer-reviewed articles in 2024.

Volume 13 of Issue 6 | Circulation. Cardiovascular quality and outcomes

Response by Ahmad et al to Letter Regarding Article "Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials".

2020

Authors: Ahmad Y, Howard JP, Francis DP

FRI0524 THE ACR’S RHEUMATOLOGY INFORMATICS SYSTEM FOR EFFECTIVENESS (RISE) REGISTRY SUPPORTS SMALL RHEUMATOLOGY PRACTICES FOR FEDERAL QUALITY REPORTING PROGRAM.

2020

Authors: Z. Izadi, T. Johansson, J. LI, G. Schmajuk, J. Yazdany

FRI0510 THE FREQUENCY OF CONTRACEPTION DOCUMENTATION IN WOMEN ON AND OFF TERATOGENIC ANTI-RHEUMATIC MEDICATIONS IN THE RISE REGISTRY.

2020

Authors: M. Clowse, J. LI, M. Birru Talabi, A. Eudy, G. Schmajuk

Annals of the rheumatic diseases

THU0395 EFFICACY OF IXEKIZUMAB ON DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AND OBJECTIVE SIGNS OF INFLAMMATION, STRATIFIED BY BASELINE CRP/SACROILIAC JOINT MRI STATUS.

2020

Authors: W. P. Maksymowych, H. Marzo-Ortega, M. ?stergaard, L. S. Gensler, J. Ermann, A. Deodhar, D. Poddubnyy, D. Sandoval, R. Bolce, A. Kronbergs, S. Liu Leage, G. Doridot, V. Geneus, A. Leung, D. Adams, M. Rudwaleit

Annals of the rheumatic diseases

THU0384 IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: RESULTS FROM THE COAST-X TRIAL AT 52 WEEKS.

2020

Authors: A. Deodhar, P. J. Mease, L. S. Gensler, P. Rahman, V. Navarro-Compán, H. Marzo-Ortega, T. Hunter, D. Sandoval, A. Kronbergs, B. Zhu, A. Leung, V. Strand

Annals of the rheumatic diseases

OP0106 SECUKINUMAB 150 MG SIGNIFICANTLY IMPROVED SIGNS AND SYMPTOMS OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM THE PHASE III PREVENT STUDY.

2020

Authors: J. Braun, R. Blanco, E. Dokoupilova, L. S. Gensler, A. Kivitz, S. Hall, H. Kameda, D. Poddubnyy, M. Van de Sande, D. Van der Heijde, A. Wiksten, B. Porter, H. Richards, S. Haemmerle, A. Deodhar

Annals of the rheumatic diseases

OP0105 EFFICACY AND SAFETY OF BIMEKIZUMAB IN ANKYLOSING SPONDYLITIS: 48-WEEK PATIENT-REPORTED OUTCOMES FROM A PHASE 2B, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY.

2020

Authors: D. Van der Heijde, L. S. Gensler, A. Deodhar, X. Baraliakos, D. Poddubnyy, A. Kivitz, M. K. Farmer, D. Baeten, N. Goldammer, J. Coarse, M. Oortgiesen, M. Dougados

Annals of the rheumatic diseases

OP0103 DOES GENDER, AGE OR SUBPOPULATION INFLUENCE THE MAINTENANCE OF CLINICAL REMISSION IN AXIAL SPONDYLOARTHRITIS FOLLOWING CERTOLIZUMAB PEGOL DOSE REDUCTION?.

2020

Authors: R. B. M. Landewé, D. Van der Heijde, M. Dougados, X. Baraliakos, F. Van den Bosch, K. Gaffney, L. Bauer, B. Hoepken, N. De Peyrecave, K. Thomas, L. S. Gensler

Annals of the rheumatic diseases

OP0060 MACHINE LEARNING BASED BERLIN SCORING OF MAGNETIC RESONANCE IMAGES OF THE SPINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS FROM THE MEASURE 1 STUDY.

2020

Authors: A. Jamaludin, R. Windsor, S. Ather, T. Kadir, A. Zisserman, J. Braun, L. S. Gensler, P. Machado, M. ?stergaard, D. Poddubnyy, T. Coroller, B. Porter, S. Mpofu, A. Readie

Neuro-oncology

European genetic ancestry associated with risk of childhood ependymoma.

2020

Authors: Zhang C, Ostrom QT, Hansen HM, Gonzalez-Maya J, Hu D, Ziv E, Morimoto L, de Smith AJ, Muskens IS, Kline CN, Vaksman Z, Hakonarson H, Diskin SJ, Kruchko C, Barnholtz-Sloan JS, Ramaswamy V, Ali-Osman F, Bondy ML, Taylor MD, Metayer C, Wiemels JL, Walsh KM